N
← Back to Search
Sponsored

Accelerate Your Clinical Trial Recruitment

Reach thousands of high-intent patients matching your specific inclusion criteria.

Start Campaign
RECRUITING Not applicable ClinicalTrials.gov

A Pilot Unrestricted Payment Program for Early-stage Cancer Patients: the PAYMENT Trial

Sponsor: Fred Hutchinson Cancer Center • ClinicalTrials.gov ID: NCT06771739

Registry updated: 2026-10-20
Ad

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Check Eligibility →

Description

This clinical trial studies whether an unrestricted cash payment program can be used to improve financial and clinical outcomes in early-stage cancer patients with financial concerns. A cancer diagnosis can have poor financial outcomes, and the cost of cancer treatment can lead to high medical debt and financial hardships for the patient and family. Financial hardship during cancer treatment is associated with adverse outcomes including poorer quality of life, lower treatment compliance, more aggressive use of hospital-based care, and worse survival. Newly diagnosed cancer patients with financial concerns may avoid treatment entirely so that they can continue to work and maintain income, provide for their families, or pay rent. An unrestricted cash payment program provides patients with a preloaded cash card once monthly. The patients can choose what to use the card to pay for and may include items like food, rent, or utilities. This provides a period of guaranteed income for the patients and may prevent them from falling into poverty and improve financial and clinical outcomes.

Interventions

  • Electronic Health Record Review (Other)
    Ancillary studies
  • Interview (Other)
    Ancillary studies
  • Support (Other)
    Receive $1000 preloaded cash card
  • Support (Other)
    Receive $100 preloaded cash card
  • Survey Administration (Other)
    Ancillary studies

Eligibility criteria

Inclusion Criteria: * Age \>= 18 * Ability to understand English * Ability to understand and willingness to sign a written informed consent document. Legally authorized representatives may sign and give informed consent on behalf of study participants * Within 90 days of a non-metastatic or early-stage solid tumor receiving or rescheduled to receive treatment in the neoadjuvant, adjuvant or definitive setting for curative intent. Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-2 * Current cancer patient at PeaceHealth (Southwest Medical Center or St. Joes) * Not current Medicaid enrollee * Not enrolled in hospice * Screens positive for financial fragility

Conditions

Malignant Solid Neoplasm

Locations

  • PeaceHealth Saint Joseph Medical Center — Bellingham, Washington, United States
  • PeaceHealth St. John Medical Center — Longview, Washington, United States
  • PeaceHealth Southwest Medical Center — Vancouver, Washington, United States
Sponsored

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record